Hoth Therapeutics Inc. (HOTH)
1.53
-0.02 (-1.29%)
At close: Jan 15, 2025, 3:59 PM
1.49
-2.61%
After-hours Jan 15, 2025, 07:43 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | n/a | 66.83K | 46.87M | 25.87K | 31.62K | 28.25K | 188.00 |
| Gross Profit | n/a | -66.83K | -46.87M | -25.87K | -31.62K | -28.25K | -188 |
| Operating Income | -7.69M | -11.07M | -14.10M | -7.30M | -7.71M | -2.50M | -1.87M |
| Interest Income | 781.00 | 6.37K | n/a | 8.00 | 25.00 | n/a | 216.00K |
| Pretax Income | -7.85M | -11.37M | -14.31M | -7.20M | -7.70M | -2.50M | -2.02M |
| Net Income | -7.85M | -11.68M | -14.31M | -7.20M | -7.69M | -2.50M | -2.02M |
| Selling & General & Admin | 4.21M | 6.13M | 6.57M | 3.96M | 5.06M | 1.22M | 1.28M |
| Research & Development | 3.48M | 4.93M | 7.53M | 2.89M | 2.12M | 1.02M | 586.84K |
| Other Expenses | n/a | 451.14K | -212.26K | 454.21K | 538.58K | 258.71K | n/a |
| Operating Expenses | 7.69M | 11.07M | 14.10M | 7.30M | 7.71M | 2.50M | 1.87M |
| Interest Expense | n/a | 305.41K | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 964.33K |
| Cost & Expenses | 7.69M | 11.07M | 14.10M | 7.30M | 7.71M | 2.50M | 1.87M |
| Income Tax | n/a | 305.41K | -1.04 | -205.25K | -10.36K | -159.92K | 2.00 |
| Shares Outstanding (Basic) | 3.41M | 1.20M | 893.20K | 494.51K | 366.58K | 376.98K | 384.48K |
| Shares Outstanding (Diluted) | 3.41M | 1.20M | 893.20K | 494.51K | 366.58K | 376.98K | 384.48K |
| EPS (Basic) | -2.3 | -9.75 | -16.03 | -14.56 | -20.99 | -6.62 | -5.24 |
| EPS (Diluted) | -2.3 | -9.75 | -16.03 | -14.56 | -20.99 | -6.62 | -5.24 |
| EBITDA | -153.15K | n/a | -14.10M | -7.30M | -7.71M | -2.49M | -2.02M |
| Depreciation & Amortization | 7.69M | 11.07M | 1.04K | 1.04K | 1.23K | 1.22K | 188.00 |